Eckert & Ziegler acquires American cancer specialist

18-Sep-2013 - Germany

Eckert & Ziegler BEBIG s.a. is to acquire the prostate cancer implants business of the American company Biocompatibles Inc. for $5 million. Biocompatibles Inc., a BTG International group company, is based in Connecticut and is the fourth largest provider of such products in the United States and generated sales of approximately €8 million in 2012. Biocompatibles Inc. had voluntarily suspended manufacture and delivery of its products in May 2013 following claims of shortcomings in its documentation of the manufacturing process by the U.S. Food and Drug Administration.

Eckert & Ziegler is now acquiring the division and hopes to remedy these shortcomings quickly so that it can resume delivery. The management expects to be able to win back customers who have migrated elsewhere as Biocompatibles has developed several innovations that improve the use of implants and has patented these unique solutions. By purchasing the division, Eckert & Ziegler will be able to offer these enhanced solutions to its European customers too. In the medium term, the Eckert & Ziegler Group intends to use Biocompatibles as an American distribution platform for its entire range of tumor irradiation products.

Other news from the department business & finance

More news from our other portals

So close that even
molecules turn red...